Reports of Patent, Design, and Trade Mark Cases, Issues 1-5; Issues 8-13Published at the Patent Office Sales Branch, 2003 - Industrial property |
From inside the book
Results 1-3 of 58
Page 22
... distinctive character in accordance with Art.3 ( 3 ) , the grounds for refusal or invalidity listed in Art.3 ( 1 ) ( a ) to ( d ) cannot apply and the shape cannot be considered devoid of distinctive character as a matter of law ...
... distinctive character in accordance with Art.3 ( 3 ) , the grounds for refusal or invalidity listed in Art.3 ( 1 ) ( a ) to ( d ) cannot apply and the shape cannot be considered devoid of distinctive character as a matter of law ...
Page 23
... distinctive character which it initially lacked and thus be registered as a trade mark . It is therefore through the use made of it that the sign acquires the distinctive character which is a prerequisite for its registration ( see ...
... distinctive character which it initially lacked and thus be registered as a trade mark . It is therefore through the use made of it that the sign acquires the distinctive character which is a prerequisite for its registration ( see ...
Page 26
... distinctive character was acquired in a monopoly situation or in some other way , the requirements of Art.3 ( 3 ) ... distinctive character which it did not have initially and can thus be registered as a trade mark . It is thus through use ...
... distinctive character was acquired in a monopoly situation or in some other way , the requirements of Art.3 ( 3 ) ... distinctive character which it did not have initially and can thus be registered as a trade mark . It is thus through use ...
Other editions - View all
Common terms and phrases
ALBERTA FERRETTI amendment Amgen amino acid Appointed Person Arsenal FC Arsenal Football Club burner cell claim 19 claimant colour common general knowledge contact lens CooperVision Court of Appeal cross-examination Davies decision defendants Directive distinctive character DNA sequence dots earlier trade mark effect erythropoietin European Patent evidence filed gene hearing officer High Court Inc v Transkaryotic infringement Integer inventive step iris section issue judge judgment Kirin-Amgen Inc lenses likelihood of confusion Ltd's Trade Mark Marks Act 1994 Meneghetti non-use opponent paragraph numbers paras Patent Office Philips Electronics NV Plc v Reed prior art priority date protein question Quickfit reason Reed Business Information referred registered trade mark registrar relation relevant Remington Consumer Products revocation shape Silverleaf specification submissions Sweet & Maxwell Synthon third party TORRES TRADE MARK 2003 Trade Mark Application trade mark proprietor Trade Marks Act Transkaryotic Therapies Inc uEPO United Kingdom word